China Medical Anti -Corruption Storm continues, and four cadres of Shanghai Pharmaceutical Group Co., Ltd. and subordinate companies have received disciplinary review and supervision investigation.
"Integrity Shanghai" WeChat public account posted on Saturday (September 2), saying that according to the news of the Discipline Inspection Commission of the Minhang District of Shanghai, Shanghai Pharmaceutical Vice President and former Chairman of Shanghai Shangko Medical Co., Ltd.Pan Deqing is suspected of serious disciplinary violations and is currently undergoing disciplinary review and supervision investigations in the Minhang District Discipline Inspection Commission of Shanghai.
In addition, Li Ping, general manager of Shanghai Shangke Medicine Co., Ltd. is suspected of serious disciplinary violations, and is currently undergoing disciplinary review and supervision investigation by the Minhang District Discipline Inspection Commission of Shanghai Minhang District;The former general manager Chen Binhua was suspected of serious disciplinary violations and is currently undergoing disciplinary review and supervision investigation by the Minhang District Discipline Inspection Commission of Shanghai Minhang District; Huang Zhenhui, the former deputy general manager of Shanghai Shangye Pharmaceutical Pharmaceutical Co., Ltd., is suspected of serious violations.District Supervision Committee Supervision and Investigation.
According to information on Shanghai Pharmaceutical's official website, the company is a large pharmaceutical industry group listed on Shanghai and Hong Kong.The company's registered capital of 3.696 billion yuan (RMB and about S $ 689 million), the main business covers the pharmaceutical industry and commerce.Shanghai Pharmaceutical is China's second largest national pharmaceutical distribution enterprise and industry -leading imported drug service platform. The company has established strategic cooperative relations with major domestic and foreign pharmaceutical manufacturers.
A video conference on the deployment of corruption issues in China ’s national pharmaceutical field was held in Beijing on July 28th. The meeting stated that the rectification of“ full chain, overall field, and full coverage ”should be carried out.The National Health and Health Commission of China said on August 15 that the centralized rectification of corruption in the country's medical field will last a year.
